Mead Johnson Nutrition has agreed to pay $12m (€10.9m) to settle a US Securities and Exchange Commission (SEC) investigation into the "promotional practices" of its Chinese business.
Mead Johnson Nutrition cannot foresee "how or when" the US Securities and Exchange Commission (SEC) will conclude its investigation into the promotional practices of its Chinese infant formula business.
US infant formula giant Mead Johnson Nutrition has bolstered its presence in the lucrative Asian market with the opening of a Singaporean research and production site.
Mead Johnson Nutrition has revealed that the US Securities and Exchange Commission (SEC) is probing “certain expenditures” relating to the promotion of infant formula products by its business in China.